Anti-Her2 CD4+ T-Helper Type 1 Response Is a Novel Immune Correlate to Pathologic Response Following Neoadjuvant Therapy in HER2-positive Breast Cancer
Breast Cancer Research - United Kingdom
doi 10.1186/s13058-015-0584-1
Full Text
Open PDFAbstract
Available in full text
Date
May 23, 2015
Authors
Publisher
Springer Science and Business Media LLC